Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration

@article{Haines2005ComplementFH,
  title={Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration},
  author={Jonathan L. Haines and Michael A. Hauser and Silke Schmidt and William K. Scott and Lana M. Olson and Paul J. Gallins and Kylee L. Spencer and Shu Ying Kwan and Maher A. Noureddine and John R. Gilbert and Nathalie Schnetz-Boutaud and Anita Agarwal and Eric A. Postel and Margaret A. Pericak-Vance},
  journal={Science},
  year={2005},
  volume={308},
  pages={419 - 421}
}
Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness in the elderly whose etiology remains largely unknown. Previous studies identified chromosome 1q32 as harboring a susceptibility locus for AMD. We used single-nucleotide polymorphisms to interrogate this region and identified a strongly associated haplotype in two independent data sets. DNA resequencing of the complement factor H gene within this haplotype revealed a common coding variant, Y402H, that… 

Multilocus analysis of age-related macular degeneration

This study validates the complement pathway's involvement in AMD and suggests that allelic variants in complement genes have a direct role in disease.

Variation in complement factor 3 is associated with risk of age-related macular degeneration

A nonsynonymous coding change in complement factor 3 is identified that is strongly associated with risk of age-related macular degeneration in a large case-control sample.

Genetics and age-related macular degeneration: a practical review for the clinician

The bulk of the available peer-reviewed evidence suggests that genetic testing is more useful as a research tool than for clinical management of patients.

A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration

A single-nucleotide polymorphism in the promoter region of HTRA1 is the most likely causal variant for AMD at 10q26 and is estimated to confer a population attributable risk of 49.3%.

Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration.

Likelihood ratio testing and conditional analyses in the case-control data set suggest that a weaker, independent protective effect exists for CC2 E318D, while polymorphisms in CC2 and CFB were strongly associated with decreased risk of AMD.

Complement C3 variant and the risk of age-related macular degeneration.

The common functional polymorphism rs2230199 in the C3 gene, corresponding to the electrophoretic variants C3S and C3F, was strongly associated with age-related macular degeneration in both the English group and the Scottish group and underscores the influence of the complement pathway in the pathogenesis of this disease.

Rare Variants in the Functional Domains of Complement Factor H Are Associated With Age-Related Macular Degeneration.

In this large A-AMD cohort, rare variants in the CFH gene were enriched and tended to be located in functional sites or led to low serum levels, which strongly implicate complement activation in A- AMD etiopathogenesis as CFH and CFI interact to inhibit the alternative pathway.

An update on the genetics of age-related macular degeneration

Variants within CFH and LOC387715/HTRA1 may contribute to the increased risk of late AMD largely through their impact on precursors, such as drusen and/or other RPE/Bruch's membrane changes.
...

References

SHOWING 1-10 OF 52 REFERENCES

Age-Related Macular Degeneration: A High-Resolution Genome Scan for Susceptibility Loci in a Population Enriched for Late-Stage Disease

The results consolidate the chromosomal locations of several AMD susceptibility loci and, together with previous reports, should facilitate the search for disease-associated sequence variants.

Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family.

RT-PCR analysis demonstrated that exon 104 of HEMICENTIN-1 is alternatively spliced in various cell types, which supports the conclusion that HEMicentIN- 1 is the ARMD1 gene.

Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease

Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease.

Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration.

Evidence for a major ARMD locus on 15q21, which, coupled with numerous other loci segregating in these families, suggests complex oligogenic patterns of inheritance for ARMD.

Genetic risk of age-related maculopathy. Population-based familial aggregation study.

The findings indicate that approximately one fourth of all late ARM is genetically determined and suggest that genetic susceptibility may play an important role in determining the onset of disease.

Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.

The interesting hypothesis that the effect of smoking on the risk of ARM is accentuated by a gene in the 10q26 region--a region implicated by four other studies is generated.

A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy

Data confirm that the APOE-4 allele, or an allele in linkage disequilibrium with it, reduces the risk of age-related maculopathy and suggest that the effect of the APoe-2 allele may vary by gender, and thatAPOE-2 may confer an increased risk only to males.
...